Celldex Therapeutics Valuation

CLDX Stock  USD 41.79  0.75  1.83%   
At this time, the firm appears to be undervalued. Celldex Therapeutics shows a prevailing Real Value of $47.7 per share. The current price of the firm is $41.79. Our model approximates the value of Celldex Therapeutics from analyzing the firm fundamentals such as Operating Margin of (8.50) %, return on equity of -0.37, and Shares Outstanding of 65.7 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Price Book
6.3973
Enterprise Value
2.3 B
Enterprise Value Ebitda
(16.72)
Price Sales
398.8884
Enterprise Value Revenue
337.7149
Undervalued
Today
41.79
Please note that Celldex Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Celldex Therapeutics is based on 3 months time horizon. Increasing Celldex Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Celldex Therapeutics is useful when determining the fair value of the Celldex stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Celldex Therapeutics. Since Celldex Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Celldex Stock. However, Celldex Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  41.79 Real  47.7 Target  59.57 Hype  41.75 Naive  41.05
The real value of Celldex Stock, also known as its intrinsic value, is the underlying worth of Celldex Therapeutics Company, which is reflected in its stock price. It is based on Celldex Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Celldex Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Celldex Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
47.70
Real Value
52.35
Upside
Estimating the potential upside or downside of Celldex Therapeutics helps investors to forecast how Celldex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Celldex Therapeutics more accurately as focusing exclusively on Celldex Therapeutics' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.75-0.69-0.65
Details
Hype
Prediction
LowEstimatedHigh
37.1041.7546.40
Details
Naive
Forecast
LowNext ValueHigh
36.4141.0545.70
Details
8 Analysts
Consensus
LowTarget PriceHigh
54.2159.5766.12
Details

Celldex Therapeutics Investments

(100.49 Million)

Celldex Therapeutics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Celldex Therapeutics's current stock value. Our valuation model uses many indicators to compare Celldex Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celldex Therapeutics competition to find correlations between indicators driving Celldex Therapeutics's intrinsic value. More Info.
Celldex Therapeutics is rated second in net asset category among related companies. It is rated third in price to earning category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Celldex Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Celldex Therapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Celldex Therapeutics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Celldex Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Celldex Therapeutics and how it compares across the competition.

About Celldex Therapeutics Valuation

The stock valuation mechanism determines the current worth of Celldex Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Celldex Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Celldex Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Celldex Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Celldex Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Celldex Therapeutics. We calculate exposure to Celldex Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Celldex Therapeutics's related companies.
Last ReportedProjected for 2024
Gross Profit3.9 M2.6 M
Pretax Profit Margin(20.55)(19.52)
Operating Profit Margin(20.64)(19.60)
Net Loss(20.55)(21.57)
Gross Profit Margin 0.56  0.59 

8 Steps to conduct Celldex Therapeutics' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Celldex Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Celldex Therapeutics' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Celldex Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Celldex Therapeutics' revenue streams: Identify Celldex Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Celldex Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Celldex Therapeutics' growth potential: Evaluate Celldex Therapeutics' management, business model, and growth potential.
  • Determine Celldex Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Celldex Therapeutics' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Celldex Therapeutics Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Celldex Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding48.4 M

Celldex Therapeutics Current Valuation Indicators

Valuation refers to the process of determining the present value of Celldex Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Celldex we look at many different elements of the entity such as Celldex's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Celldex Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Celldex Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Celldex Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Celldex Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Celldex Therapeutics' worth.
When determining whether Celldex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Celldex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Celldex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Celldex Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.
Note that the Celldex Therapeutics information on this page should be used as a complementary analysis to other Celldex Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Celldex Stock analysis

When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is Celldex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. If investors know Celldex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celldex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.92)
Revenue Per Share
0.142
Quarterly Revenue Growth
1.561
Return On Assets
(0.22)
Return On Equity
(0.37)
The market value of Celldex Therapeutics is measured differently than its book value, which is the value of Celldex that is recorded on the company's balance sheet. Investors also form their own opinion of Celldex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Celldex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celldex Therapeutics' market value can be influenced by many factors that don't directly affect Celldex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celldex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Celldex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celldex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.